• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Osteologix

Boston Scientific pours another $37 million into overseas R&D

August 9, 2011 By MassDevice staff Leave a Comment

Boston Scientific

More news from the Emerald Isle as the Boston Scientific Corp. (NYSE:BSX) plans to spend $37 million on overseas research and development, this time at its R&D facility in Clonmel, Ireland.

The Natick, Mass.-based company hopes to jump-start development of a next generation cardiac rhythm management system.

Filed Under: News Well, Research & Development Tagged With: Boston Scientific, Cardiac Rhythm Management, Delcath Systems Inc., Osteologix

Updated: Greener pastures lure Delcath and Osteologix, more details emerge

August 9, 2011 By MassDevice staff Leave a Comment

Updated 8/8/2011 7:15 p.m.

Osteologix
Ireland
Delcath

Filed Under: News Well, Oncology, Pharmaceutical, Wall Street Beat Tagged With: Delcath Systems Inc., Osteologix

Greener pastures lure Delcath and Osteologix

August 8, 2011 By MassDevice staff Leave a Comment

Osteologix
Ireland
Delcath

Delcath Systems Inc. (NSDQ:DCTH) and Osteologix Holdings plc (PINK:OLGXF) planted roots in Ireland this month.

Filed Under: Oncology, Pharmaceutical, Wall Street Beat Tagged With: Delcath Systems Inc., Osteologix

Osteologix exits stock market, U.S.

December 15, 2010 By MassDevice staff Leave a Comment

OLGX logo

Osteologix Inc. (OTC:OLGX) decided to pull up stakes in the U.S. and remove its stock from public trading.

In an effort to cut costs, the company plans to deregister its stock on the NASDAQ exchange and close its U.S. office in Glen Allen, Va., in order to consolidate into its Dublin, Ireland-based subsidiary Osteologix Holdings Ltd.

Filed Under: Business/Financial News, News Well, Orthopedics, Pharmaceutical Tagged With: Osteologix

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy